Adaptin Bio, Inc. SEC filings APTN

Adaptin Bio, Inc. has 75 filings in SEC EDGAR's recent list, going back to Aug 10, 2023. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 25, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
8-K Current report
Other events
 Aug 25, 2026 Aug 20, 2026
8-K Current report
Other events
 Apr 6, 2026 Apr 6, 2026
8-K Current report
Material agreement, Unregistered share sale
 Dec 23, 2025 Dec 22, 2025
8-K Current report
Officer or director change, Other events
 Oct 6, 2025 Oct 3, 2025
8-K/A Amended current report
Acquisition or sale of assets
 Apr 15, 2025 Feb 11, 2025
8-K Current report
Other events
 Apr 9, 2025 Apr 7, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
 Feb 18, 2025 Feb 11, 2025

Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
APTN (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Charlotte, NC
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1938571
Former names
Unite Acquisition 1 Corp. (until Feb 13, 2025)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.